KCT0009058招募中Unknown
AI-based Novel Diabetes Classification and Prognostic Prediction in Korean cohort studies: a gateway to precision medicine in diabetes
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 19(Year) 至 79(Year)（—）
- 性别
- All
入选标准
- •Patients diagnosed with type 2 diabetes within the last 3 years
- •Age 19 and above, under 80
排除标准
- •Patients with type 1 diabetes
- •Those currently taking medications such as systemic steroids, obesity treatment drugs, or other medications that can affect current blood glucose levels
- •Patients deemed inappropriate for clinical research (e.g., pregnant individuals, severe systemic illnesses, mental disorders, etc.)
研究者
相似试验
进行中（未招募）
不适用
Clinical trial of patients with type 2 diabetes and obesity randomly allocated to be implanted with an intestinal liner device with or without standard diabetes liraglutide medical therapy or liraglutide alone.Combined Type 2 diabetes mellitus and obesity.MedDRA version: 14.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-004988-42-GBSandwell and West Birmingham Hospitals NHS Trust
Unknown
不适用
A Single Center Study on Comparing the Different Function of EndoAngel in Improving the Quality of ColonscopyAdenomaNCT04453956Renmin Hospital of Wuhan University1,090
Unknown
2 期
Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by InflammatioPatients with IgA nephropathyIgA nephropathyD41.0LBCTR2020023394ovartis Pharmaceuticals4
进行中（未招募）
1 期
Two-part Clinical Study to Evaluate the Safety and Benefits of NaBen® in Adolescents with SchizophreniaTreatment for Schizophrenia in AdolescentsMedDRA version: 20.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2017-001168-39-PLSyneuRx International (Taiwan) Corp126
进行中（未招募）
1 期
Two-part Clinical Study to Evaluate the Safety and Benefits of NaBen® in Adolescents with SchizophreniaTreatment for Schizophrenia in AdolescentsMedDRA version: 20.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2017-001168-39-GBSyneuRx International (Taiwan) Corp126